Detalhe da pesquisa
1.
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.
N Engl J Med
; 388(14): 1284-1295, 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018492
2.
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL.
Blood
; 142(2): 146-157, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172203
3.
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells.
Haematologica
; 106(4): 987-999, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381575
4.
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.
Clin Cancer Res
; 30(11): 2545-2557, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551501
5.
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies.
Nat Commun
; 14(1): 3423, 2023 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296093
6.
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.
Front Immunol
; 14: 1194225, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304298
7.
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies.
Cells
; 11(12)2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35741048
8.
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
J Hematol Oncol
; 15(1): 163, 2022 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335396
9.
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
J Natl Cancer Inst
; 114(3): 436-445, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581788
10.
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma.
J Hematol Oncol
; 14(1): 191, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772439
11.
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies.
Front Immunol
; 12: 755639, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737753
12.
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135100
13.
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαß/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Front Immunol
; 11: 699, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477328
14.
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring.
J Immunol Res
; 2020: 1938704, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32322591
15.
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring".
J Immunol Res
; 2020: 2698258, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851098
16.
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma.
Oncoimmunology
; 7(6): e1433518, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872565
17.
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.
Cancer Res
; 78(12): 3337-3349, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615432
18.
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders.
Curr Hematol Malig Rep
; 12(1): 68-78, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116633
19.
Why do we need IgM memory B cells?
Immunol Lett
; 152(2): 114-20, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23660557